Aquestive Therapeutics Inc (AQST NASDAQ) stock market data APIs

$2.8556 0.09(3.3%)
as of March 18, 2025

Aquestive Therapeutics Inc Financial Data Overview

Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder; and Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures. The company's proprietary pipeline of complex molecule products includes AQST-108, which is in phase 2, a sublingual film formulation delivering systemic epinephrine for the treatment of conditions other than anaphylaxis; and Anaphylm, which is in phase 3, an epinephrine sublingual film for the emergency treatment of allergic reactions, including anaphylaxis. In addition, it develops PharmFilm technology for patients suffering from certain central nervous system disorders and Adrenaverse, an epinephrine prodrug platform. The company was incorporated in 2004 and is headquartered in Warren, New Jersey.

Prev. Close 2.763
Open 2.8556
High 2.869
Low 2.7053
52 wk Range 2.24-5.8
Market Cap 272 M
Shares Outstanding 98 871 K
Revenue 57 561 K
EPS -0.1607
Beta 2.759

Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get Aquestive Therapeutics Inc data using free add-ons & libraries


Get Aquestive Therapeutics Inc Fundamental Data

Aquestive Therapeutics Inc Fundamental data includes:

  • Net Revenue: 57 561 K
  • EBITDA: -30 030 000
  • Earnings Per Share:
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get Aquestive Therapeutics Inc Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: 2025-03-03
  • EPS/Forecast: -0.1325
GET THE PACKAGE

Get Aquestive Therapeutics Inc End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE

Aquestive Therapeutics Inc News

Get Apple Inc fresh news feed via Financial News API

Calendar & News package for

$19.99/mo.

Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
  • Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat